CHILDRENS HOSPITAL OF WISCONSIN
1. Target Overview & Investment Thesis
CHILDRENS HOSPITAL OF WISCONSIN is a 298-bed safety-net/medicaid heavy in MILWAUKEE, WI with $795.1M in net patient revenue and a 5.0% operating margin. The hospital serves a payer mix of 0.1% Medicare, 28.5% Medicaid, and 71.4% commercial.
Thesis: Platform Growth. Our ML models identify $58.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.0% to 12.4% (+736bps).
| Net Revenue HCRIS | $795.1M |
| Current EBITDA COMPUTED | $39.9M |
| Operating Margin COMPUTED | 5.0% |
| Occupancy HCRIS | 64.7% |
| Revenue / Bed COMPUTED | $2.7M |
| Net-to-Gross HCRIS | 54.3% |
| Distress Probability ML | 50.8% |
2. Market Context & Competitive Position
WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 5.0% places it above the state median. Among 24 size-comparable peers (149-596 beds), the median margin is 0.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (149-596), prioritizing same-state peers. 24 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CHILDRENS HOSPITAL OF WISCONSI (Target) | WI | 298 | $795.1M | 5.0% |
| MARSHFIELD MEDICAL CENTER | WI | 194 | $765.7M | -13.0% |
| MCHS EAU CLAIRE HOSPITAL | WI | 186 | $676.4M | -5.5% |
| BELLIN MEMORIAL HOSPITAL | WI | 175 | $652.3M | 13.7% |
| ST. VINCENT HOSPITAL | WI | 237 | $649.4M | 1.9% |
| ASPIRUS WAUSAU HOSPITAL | WI | 239 | $645.7M | 3.1% |
| AURORA BAYCARE MEDICAL CENTER | WI | 190 | $558.0M | 17.6% |
| WAUKESHA MEMORIAL HOSPITAL | WI | 270 | $545.6M | 3.2% |
| ASCENSION COLUMBIA ST MARYS MI | WI | 382 | $524.4M | -12.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $58.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $16.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $15.9M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $15.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $9.7M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $509K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $39.9M |
| + RCM Uplift | +$58.5M |
| Pro Forma EBITDA | $98.4M |
| Current Margin | 5.0% |
| Pro Forma Margin | 12.4% |
| WC Released (1x) | $30.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $61.3M | $848.2M | 13.83x | 69.1% |
| Base (11x exit) | 10.0x | 11.0x | $61.3M | $953.0M | 15.54x | 73.1% |
| Bull Case | 9.0x | 11.0x | $55.2M | $1.17B | 21.12x | 84.1% |
| Bull (12x exit) | 9.0x | 12.0x | $55.2M | $1.29B | 23.34x | 87.8% |
| Bear Case | 11.0x | 10.0x | $67.5M | $535.7M | 7.94x | 51.3% |
| Bear (11x exit) | 11.0x | 11.0x | $67.5M | $611.2M | 9.06x | 55.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Elevated Medicaid exposure (28.5%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| High | Elevated distress probability | Model estimates 50.8% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 24 hospitals with 149-596 beds
- Same-state prioritization (n=25)
- Comp margins: P25=-12.3% / P50=0.8% / P75=6.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.